Lidocaine 1% PF — Class II drug recall D-121-2013
Terminated recall by New England Compounding Center, reported 2013-01-09, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-121-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | New England Compounding Center, Framingham, MA, United States |
| Recall initiated | 2012-09-26 |
| Classified | 2012-12-31 |
| Reported by FDA | 2013-01-09 |
| Terminated | 2016-10-07 |
| Distributed | Nationwide (US) |
| Quantity | 3,321 vials |
| Reason classes | sterility |
Product
Lidocaine 1% PF, 2% PF, and 4% PF, in 1 mL, 2 mL, 5 mL, and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-121-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.